跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MARCAINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MARCAINE
Authorized
STANDARD
MARCAINE
SEPTODONT, INC.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6599dbf663535d01
Company
SEPTODONT, INC.
Type
Standard
Approval Details
Approval Id
6599dbf663535d01
Drug Approval Canada Name
MARCAINE
Product Name
MARCAINE
Status
Marketed
Status Date
2019-04-12
Original Market Date
2019-04-12
Din
02474247
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Block/Infiltration
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB51 BUPIVACAINE, COMBINATIONS
Atc Name
n 01 bb 51
Aig Number
0231290002
Company Name
SEPTODONT, INC.
Company Address
25 Wolseley Court, Cambridge, Ontario, Canada, N1R 6X3
Company Detail Path
/organization/septodont-inc
Company Information
Pharmaceutical Company Name
SEPTODONT, INC.
Country Name
United States
Province Name
Delaware
City Name
new castle,delaware,country_us
Address
245 Quigley Blvd Ste C
Active Ingredients
BUPIVACAINE HYDROCHLORIDE
5 MG / ML
EPINEPHRINE BITARTRATE
0.0091 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6599dbf663535d01
Type
Standard
Back to Health Canada Approvals